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Objetive: To evaluate the new Vitek2 ID-YST system for the identification
of yeast.
Methods: We study 163 yeasts strains (43 C. parapsilosis, 31 C. albicans, 20 C.
tropicalis, 19 C. glabrata, 19 C. krusei, 10 C. lusitaniae, 6 C. Jamata, 4 C.
guil/iermondii, 2 C. ktJyr, 2 Rhodotorula spp., 3 Trichosporon spp., 2 Sacchar-
omyces cerevisiae, 1 e. zeylanoides, 1 C. inconspicua and 1 Cryptococcus neoJor.
mans) isolated from clinical specimens. The API 20 C system (bioMerieux,
Spain) was considered the reference standard for the purposes of this study.
The~ strains were tested by the Vitek2 ID-YST system (bioMerieux. Spain)
according to the manufacturer's recomendations. Discrepancies between
both methods were repeated by both systems.
Results: The Vitek21D-YST system identified correctly 147 (90%) yeasts
strains at 18 hours. The most common Candida species and e. neoJormans were
identified correctly. C. zeylanoides y 1 T. cutaneum isolates were not
identified. Founcen isolates were misidentified: 5 C. Jamata as C. tropicalis
and one as R. glutinis, 1 C. kifyr as C. sphaerica, 1 C.lerusei as G. capitatum, I
C. parapsilosis as e. intennedia, 1 e. inconspicua as C. capitatum. Trirhosporon
and Rhodotorula misidentified specie level.
Condusions: The new Vitck2 ID-YST system was a good and alternative
method to identification of Candida spp. and other yeasts. although another
identification tests could be used to some uncommon yeasts.
ITuP284IIdentification of C. dubliniensis from dinical
specimens by Vitek2
A. Valverde. S. Bernal, M. Chavez. G. Quindos l , E. Martin
Microbiology S., Valme U.H., Seville; 'D. Microbiology, Euskadi Univ.,
Bilbao, Spain
Objetive: To evaluate the Vitek2 10-YST system for identification of the
new emergent yeast Candida dubliniensis from clinical specimens.
Methods: A total of 34 e. dubliniensis strains from clinical isolates were
tested by Vitek2 ID-YST system (bioMerieux, Spain) according to the
manufacturer's recomendation. All strains were previously identificated by
an indirect inmunofluorescence test with an anti-e. dubliniensis serum (J Clin
Microbioll998; 36:2428-2433) was considered the reference standard for the
purpose ofthis study. Although other additional tests were use as: germ tube.
morphology agars, do not growth or poor growth at 42°C and biochemical
tests. Discrepances identification between both methods were evaluated by
repeat testing.
Results: The Vitek2 ID-YST system identified correctly 31 (94%) e.
dubliniensis strains. Three strains were misidentified as C. albicans.
Condusions: The Vitek2 ID-YST system could be a good. easy and rapid
alternative to identify the e. dubliniensis isolates. without additional tests.
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ITuP28S1 Preliminary evaluation of LCx HIV RNA quantitative
assay
E. Tanzi, A. Amendola, D. Colzani. R. Pulvirenti l , C. Galli l , A. R.
Zanetti
Institute of Virology, University ojMilan; 'Scientific Affairs, Abbott
Diagnostics Division, Rome, Italy
Objectives: to evaluate the performance characteristics ofa new assay for the
quantitative detection ofHIV-RNA (Abbott LCx HIV RNA Quantitative)
in comparison with another target amplification method (Organon Nucli-
Sens) on samples from well characterized HIV-l positives.
Methods: we studied 60 patients, ofwhom 22 enrolled in a clinical trial for
combination therapy and 38 were vaccinated against influenza in the winter
of 1998-'99. NudiSens testing had been performed on fresh plasma, while
LCx was used retrospective lyon frozen samples (145 from the former and
143 from the latter group). The LCx method is based on RNA extraction by
QIAAmp followed by a competitive R T-PCR. Results are read by MEIA
technology on the automated LCx instrument; the ratio of the fluorescence
signal of the internal standard with the one of the target sequence amplifica-
tion is compared with a stored 6-points external curve. The sensitivity is 178
RNA copies/mL with 0.2 mL ofplasma (employed in the study) and reaches
50 copies/mL with 1 mL of sample. with a 5-log dynamic range.
Results: the precision on assay controls replicates ranged from 2.6% to
6.2%. On treated patients the sensitivity of the 2 assays was similar
(qualitative agreement: 90.3%). LCx showed a tendency to give higher
values. A significant difference (> 1 log) was recorded in 12 samples (8.3%)
and in 11 patients (50%) at least one result was different. but the trends of
HIV-RNA variations over time were identical or very similar in all cases.
On vaccinated subjects. tested to verify the effects of the flu vaccine on HIV
replication. many samples were NucliSens + /LCx - and a variation (0.5 log
or more) in RNA values was noted in 31.6% of patients by Nuclisens vs.
18.4% by LCx (p = n.s.).
COndusions: the LCx assay showed a very good precision. was easy to use
and showed a good sensitivity. From our experience it appeared well suited
for the monitoring of HIV-1 viral load in treated as well as in untreated
patients.
[TuP286! Comparison of quantitative measured of hepatitis
Cvirus RNA in fresh and one freeze-thaw serum samples
R. Mistik. M. Sinirtas. B. Ener
Uludag University, School ojMedicine Department ojClinical Microbiology
and Infectious Diseases Bursa, Turkey
Objectives: Quantification ofhepatitis C virus (HCV) RNA is valuable pan
of the clinician's armamentarium for managing patients with hepatitis C.
For this purpose, Quantiplex HCV-RNA Assay (Chiron Coop. USA) that
determines quantitative levels by branched DNA (bDNA) technology.
According to the test procedure, the results are affected by freezing-thawing
cycles and also by storing conditions but it is reponed that this effect i>
minimal after several cycles.
Methods: Blood samples were collected from 18 patients whom are known
to be positive for HCV-RNA. All samples were tested freshly by Quanti-
plex Assay (HCV-RNA 2.0 Assay, Chiron Coop.). Then ten samples were
stored at -18°C and eight samples were stored at -74°C for one month.
After one month all ofthem were thawed and tested by the same Quantiplex
assay. The quantitative values of HCV-RNA in fresh serums were the
baseline values and decreased or increased measurements obtained in the
stored samples were compared by these baseline values.
Results: As a results; 9% increasment for the value in stored samples at
-74°C (95% CI, SE: 0.086. p > 0.05). and 27% decreasment for the value in
stored sample at 18°C (95%, CI. SE: 0.051. p < 0.001).
CondusloM: In this repon. it is found that the quantification levels ofHCV-
RNA was affected by freezing-thawing and also degree ofthe temperature.
So for the usefullness ofQuantipiex assay, and reliable results for clinicians all
the samples should be measured at the same manner and ifsamples are stored
it should be preferred in stored at -74°C..
!TuP287I Comparison of the Cobas Amplicor HBV Monitor Test
and the Amplicor HBV Monitor Test
I.). MarinI, M. Poljakl , K. Semel,). Volkar-Meglic2, M. MatiCic2, V.
Brinovec2
'Inst. ojMicrobiol.; 2InJect. Dis. Depart., Clinical Center, Ljubljana, Slovenia
Objectives: The present study compared the performance oftwo versions of
the Amplicor HBV Monitor Test (Roche Molecular Systems, Branchburg,
NJ) for quantification ofhepatitis B virus (HBV) DNA in serum samples: the
new automated Cobas Amplicor HBV Monitor Test and the manual
microwell plate-based Amplicor HBV Monitor Test.
Material and Methods: 208 serum samples from the same number of
randomly selected. hepatitis B surface antigen positive patients from
Slovenia were tested using both test versions.
Results: Quantification of HBV DNA by the Cobas Amplicor HBV
Monitor Test and the Amplicor HBV Monitor test revealed no significant
difference in sensititviry between the two assays. 183 samples tested positive
and 20 negative by both test versions. Discordant results were obtained in 5
samples (3 samples tested positive by automated version only and 2 samples
tested positive by manual version only). HBV DNA concentrations deter-
mined by two test versions were highly correlated (N = 183, r = 0.97, P <
0.00(1) and were in good agreement (mean difference in 10gtO copies/ml ±
1.% standard deviations = 0.387 ± 1.139).
COndusion: The results of the study indicate that the new automated Cobas
Amplicor HBV Monitor Test could replace the microwell plate version of
the Amplicor HBV Monitor Test. The major inconvenience of the Cobas
Amplicor HBV Monitor Test is the required performance ofserial dilutions
of serum samples with high HBV DNA concentrations in order to extend
the narrow linear range of the assay.
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Adenovirus culture
Conclusion: a strong re.ctivity by AxSYM is confirmed ny Inno-LIA in
98.3% ofeases and has a PPV of98.3% for viremia, as compared to 79.4% by
LlA.
LlAI LlAMI LlAMI Li. PI LlA PI
AxSYM PCR- PCR- PCR+ PCR- PCR+
Neg.tive 22 11 0 0 0
Weak 8 20 2 21 2
Medium 0 1 2 23 30
Strong 0 3 0 8 169
Total 30 35 4 52 201
• RSV pos (133) lnjluttlzavirus pos (36) Parainjlurnzavirus pos (/8) no virus dtucred
(72) sttlsitiviry 88.6% negative p"dictive value 97.5%
Conclusion: The negative predictive value of the R VS assay is very high in
our population (97.5%). Since culture for Admovirns is cosdy and time
consuming, and the benefit in a R VS-assay negative population is very
limited, culture for Adenovirns seems no longer indicated.
!TuP2901ldentification and monitoring of CMV infection in
renal transplant recipients
J. Siennickal, M. Durlikz, B. Litwinska l , A. TrlcIDska l , A. Chmuraz, D.
Lewandowskaz, M. Laoz, L P~czekz, M. Kantoch l
'National Institute of Hygiene; ZInstitute of Transplantology, Warsaw, Poland
Objectives: To determine the most usefulness method for diagnosis of
CMV infection in renal transplant recipients.
Methods: Samples from 41 consecutive renal transplant recipients collected
5-6 times during the first 3 postoperative months (mean time 95.5 days)
were investigated by ELISA (IgG, IgM), Western blot (WB), shell vial (sv),
antigenemia assay (pp65), the immunofluorescent method (IF), PCR and
hybridization (HCS).
Results: CMV infection was confirmed by at least 1 method in all patients.
ELISA IgM confirmed infection in 12 patients, WB - 35, sv - 24, pp65 - 28,
HCS - 27, PCR - 26 and IF - 20. Clinical manifestation ofCMV infection
was observed in 11 patients. Only results of HCS and PCR were statistica
correlated with symptomatic infection. Comparison of the cap.city of these
two tests to diagnose symptomatic infection shown better parameters for
HCS performed by quantitative variant, especially for DNA levels greater
than 60 pg/ml.
Conclusions: The hybridization and PCR methods seem to be the most
usefulness for diagnosing of CMV infection in renal transplant recipients.
HCS made in quantitative variant allows both detecting and monitoring the
infection. The ativiral treatment should start at CMV DNA level of60 pgl
ml or in case of increasing of the level in successive samples. It seems to be
necessary to monitor renal allograft recipients for CMV infection at least
once a week.
ITuP291[ Evaluation of EBV diagnostic methods in different
clinical cases
V. Tormanen, E. K. Pisa
AB Sangtec Medical, Bromma, Sweden
In carriers of HBV, disapperance of HBe antigen and the presence of anti-
HBe antibodies is associated with a clearance of HBV DNA in serum and
resolution of the infection. Despite seroconversion to anti-HBe some
patients exhibit high concentrations of HBV DNA in serum. In these
patients a great majority (> 90%) of isolated HBV strains were character-
ized by a G to A mutation at nucleotide 18%. The mutation is introducing a
stop codon in a HBe antigen defective hepatitis B virus.
Since HBeAg is an important target in the immune mediated killing of
hepatocytes, these variants represent escape mutants i.e hepatocytes infected
with the mutants survive immuntargeting and mutant virus is free to infect
neighbouring cells prolonging infection. It has been suggested by Bonino
et al. that these HBe negative mutants are important determinants of the
outcome of chronic hepatitis B infections and influencing the outcome of
interferon treatment.
ITuP292I Routine assay for quantitatlon of HBeAG negative
hepatits Bvirus
B. Litwinska, A. Trzciitska, J. Siennicka
Dept. of Virology, National Instytute ofHygiene, Warsaw, Poland
Objectives: To compare different diagnostic methods for identification of
EBV infections.
Methods: 40 serum samples collected from clinical cases of E-B virus
suspected etiology were tested by different methods: Western blot- WB
(IgG and IgM antibodies to EBV antigens: VCA (P23), EA-D (P54). EA
(pl38), EBNA-l (p27) were detected); ELISA (detection ofIgM antibodies
to VCA and IgG antibodies to VCA. EA, EBNA); IF assay (the same type of
antibodies like in ELISA were detected).
Results: Only in 47.5% ofserum samples the same resultes in all comparing
methods were obtained. The most correlation was seen in the case ofELISA
and IF assay (67.5%), lower between ELISA - WB (60%) and IF - WB
(60%).
Conclusions: Obtained 67.5% correlation between ELISA and IF was
unsatisfactory. It makes a gre.t problems, because, ELISA and IF are the
diagnostic methods in general use in identification ofEBV infections. Other
problems were also related with criteria ofinterpretation of the same results
obtained in different tests, which were used (especially in the case ofWB test)
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ITuP288 I Evaluation of the 'Respiratory Viral Screen kit (RVSY
for the detection of Adenovirus antigen.in respiratory samples
by immunostaining
P. Bruynseelsl , B. Weisel, M. Boersl, M. Van de Vyverez, A. Mertensl
1AZ Middelheim; ZAZ Stuivenberg, Antwerp, Belgium
Objective: We evaluated sensitivity ofan indirect immunofluorescence (IF)
assay for the detection ofAdenovirus using shell vial and conventional culture
as reference methods.
Materials and Methods: The R VS kit (Light Diagnostics-Chemicon) is an
indirect IF technique for the qualitative detection ofviral antigens in clinical
samples. The antiserum consists of a mixture of monoclonal antibodies
directed against Influenza A and B, Parainfluenza 1, 2 and 3, RSV and
Adenovirus.
For the detection of Adenovirus, shell vial as well as conventional culture
on Hep2 cells were used. 498 naso-pharyngeal aspirates (npa) from 455
patients were tested over a period oft 2 months. Age ranged from 10 days to
44 years.
Results: IF pos: 298 samples (59.8%), IF neg: 200 samples (40.2%).
!TuP289I HCV RNA and anti-HCV reactivity by MEIA or Inno-
UA supplemental assay on routine patient samples
V. Bossi, G. C. Paggi, C. Galli l
Virology, Hospital "Amedeo di Savoia", Turin; IScientijic Affairs, Abbott
Diagnostics, Rome, Italy
Objectives: to evaluate the relationship between HCV RNA positivity and
anti-HCV antibodies detected by a screening and a supplemental assay and to
establish the optimal strategies for the serological diagnosis of HCV infec-
tion.
Methods: we considered 323 unselected consecutive sera from our routine
(in- and outpatients) that were reactive by a commercial EIA. All samples
were tested by: 1) Abbott AxSYM HCV 3.0, an indirect MEIA screening
assay with recombinant Core, NS3 NS4 and NS5 antigens; 2) the Inno-LIA
supplemental assay, that discriminates the reactivities to 2 peptides and to E2,
NS3, NS4 and NS5 antigens/peptides; 3) a qualitative HCV-RNA target
amplification method (Amplicor, Roche). AxSYM results were classified as
negative (N) and reactive at different samplelcutoff (SIC0) ratios, with a SI
CO value of 1-10 being considered a weak, 11-50 a medium and > 50 a
strong reactivity. Inno-LIA results were scored as: a) positive (P), when a
score ~ 1+ for at least 2 antigens was present; b) monoreactive (M, ~1 + for
a single antigen, including the 2 core peptides); negative (N), no no bands or
weak signal « 1).
Results: 1 sample negative by MEIA/LIA and PCR + (seroconversion,
positive by MEIA after 8 weeks); other results in the Table.
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In order to investigate the role of HBe negative hepatitis B virus in
treatment outcome of new anti-virals a routine assay was needed.
A solid-phase minisequencing assay with colorimetric detection was
developed for quantitative analysis of HBeAg negative and wilt type
hepatitis B virus.
[TuP293] A highly standardized method for monitoring of
anti-viral treatment of human cytomegalovirus
Vuokko Tormanen, Benita Zweygberg Wirgart, Eva K. Pisa
AB Sangtec Medical, Bromma; Department ofClinical Microbiology, Section of
Virology, Karolinska Hospital, Stockholm, Sweden
Human cytomegalovirus (hCMV) represents an important opportunistic
pathogen in immunocompromised hosts eg transplant recepients and AIDS
patients. The last decade has given us a number of eflictive anti-virals with
yet more to come. They all have one in common. the need of a sensitive,
reliable and robust test for monitoring of drug effictivness.
PCR is widely applied in a number of laboratories but in many multi-
center clinical trials no standardisation of the method has been performed.
Sample preparation of serum/plasma is important in determining the
reproducibility of any quantitative system. Therefor a standardized three
step sample preparation method was introduced. A quantitative assay was
developed which utilises the 96 well format and has a colorimetric read-out.
The test has an internal standard and a standard curve is generated in each run
enabling 41 patient samples per 96 well plate. The test requires standard
laboratory equipment only and is amenable for automation. The test has
been validated against an in-house nested PCR and shown to have the same
sensitivity and an increased specificity.
!TuP2941 Evaluation of a new CMV IgG avidity test
I. Glynoul, M. Simout, K. Benetoul, H. Kada!, H. Tsiolkas2
IMicrobiology Dept., "Helena Venizelou" Maternity Hospital, Athens,
Greece; 2bioMerieux
Objective: To evaluate a new IgG Avidity test in order to exclude recent
CMV infections.
Methods: A total ofS5 serum samples from pregnant women who attended
the Outpatient Dpt. of our Hospital were tested by Micropaeticle Enzyme
Immuno Assay (MEIA, AXSYM, ABBOTT) as routine method for the
detection ofigG and IgM antibodies and Enzyme Linked Fluorescent Assay
(ELFA. VIDAS. bioMerieux) for Ip;G Avidity. As complementary method
for IgG and IgM detection VIDAS CMV IgG and VIDAS CMV IgM were
used.
Results: Two groups of pregnant women were studied: 81 women with
IgG and IgM positive result (group 1) and 4 with only IgM positive result
(group 2) with the MEIA method. In 76/81 (93.8%) cases (group 1) recent
infection was excluded by using VIDAS CMV IgG Avidity test. simulta-
neously with paired sera testing. 4 cases could represent primary infection
with both methods and confirmed by VIDAS CMV IGM (bioMerieux) and
only one remained undetermined. In the 2nd group all specimens retested.
using VIDAS CMV IgM. were proved to be false positive using the MEIA
method.
Condusions: VIDAS CMV IgG Avidity test has excluded > 90% of
suspected primary CMV infection even from the first collection. The
Avidity test could be very useful in the diagnosis of primary infection.
especially when routine methods have doubtful results, as it is well known
that during pregnancy, time is valuable for the prevention offetus infection
and disease.
ITuP29SI A multiplex nested polymerase chain reaction assay
in cerebrospinal fluid of patients with presumed herpetic central
nervous~minfections
E. Arresel, M. Basaras!, M.J. Fernandez2• M. Imaz2, R. Cisternal.;!
I University ofBasque Country; 2Basurto Hospital, Bilbao, Spain
To facilitate early diagnosis of herpes virus infection of the central nervous
system (CNS), a multiplex nested polymerase chain reaction (PCR) assay
was developed to test simultaneously for the presence ofherpes simplex virus
(HSV) types 1 and 2, varicella zoster virus (VVZ). cytomegalovirus (CMV),
hum"n herpesvirus-6 (HHV~) and Epstein-Barr virus (EBV) DNA in the
cerebrospinal fluid (CSF) of HIV-negative patients with herpetic CNS
disease suspected on clinical grounds. The aim of the present study was to
improve the utility ofthe multiplex nested peR technique for routine use in
a diagnostic laboratory. .
Methods: A multiplex nested PCR assay was developed to allow rapid,
sensitive and simultaneous detection ofherpesviral DNA specific sequences
(Radar-Real). The method involves a multiplex nested PCR in which the
combination of primers amplifies specific herpesviruses. We examined 70
CSF of HIV-negative patients with presumed herpetic CNS infections by
multiplex nested PCR.
Results: DNA of herpesvirus was detected in CSF from four (5.7%) of the
70 HIV-negative patients with neurologic disease. HSV DNA was detected
in one patient and VZV DNA was found in CSF from three patients. In the
present study. CMV, HHV~ and VEB were not detected in any of the
samples of the HIV-negative patients with CNS disease.
Conclusions: This multiplex nested PCR provides a rapid. sensitive and
specific method to detect and differentiate herpesvirus infection. This
preliminary study demonstrates the value of testing for five different
herpesviruses simultaneously by a sensitive and straightforward technique
rather than screening only for those viruses that are causing infections as
suggested by clinical signs.
ITUP296I Detection of specific DNA of herpesvirus by
polymerase chain reaction in cerebrospinal fluid of HIV·infected
patients with central nervous~m diseases
E. Arrese!, M. Basaras!, M. J. Fernandez2, M. Imaz2, R. Cisternal.;!
IUniversity ofBasque Country; 2 Basurto Hospital, Bilbao, Spain
Disorders of the central nervous system (CNS) frequendy complicate the
course of HIV infection. These may be the consequence of infection of the
CNS by HIV itself or be associated with opportunistic infections. Oppor-
tunistic viral infections of the CNS include those caused by herpesviruses,
herpes simplex virus (HSV) types 1 and 2, varicella zoster virus (VZV),
cytomegalovirus (CMV). human herpesvirus-6 (HHV~) and Epstein-Barr
virus (EBV). Recendy. polymerase chain reaction (PCR) has been proposed
for diagnosis of some neurological diseases. In the present study, CSF
samples from patients with HIV infection and CNS symptoms were
examined by PCR for detection ofherpesvirus DNA.
Methods: In this srudy, CSF samples from 80 patients with HIV infection
and CNS symptoms were examined by multiplex nested PCR (Radar-
Real). These methods involves a multiplex nested PCR in which the
combination of primers amplifies specific herpesvirus DNA. Individual
viruses were then detected and differentiated by the size of their PCR
producrs determined Uliing ethidiuJll bromide .taincd agaro.c gcI..
Results: We tested 80 CSF samples from patients with CNS diseases. A
positive result was obtained in 17 (21.3%) patients. HSV was found in one
patient, VVZ was detected in four patients, CMV was found in CSF from
seven patients, HHV~ was detected in one CSF and EBV was detected in
four patients.
Conclusions: Multiplex nested PCR from CSF has great relevance for
diagnosis of herpesvirus CNS diseases in H1V-infected patients as demon-
strated by its high sensitivity, specificity and the frequency of positive
findings.
ITuP297I Cytomegalovirus (CMV) IgM reactivity. immunoblot
patterns and Ig6 avidity in routine patient screening
T. Lazzarotto!, M. P. Landini l • R. Rescaldani2, R. Vezzo2• A. La GioiaJ ,
C. MartinelliJ • S. La Rocca4, G. Agresti4, R. Pulvirenti5, C. Galli5
Microbiology; I University IifBOl0f':'.; 2Hospital ofMonza; General Lab;
JHospitals ofLivomo; 4Grosseto; Abbou Diagnostics, Roma, Italy
Objectives: AxSYM CMV IgM is an automated MEIA indirect assay that
employs recombinant antigens (rAg) from major structural and non-
structural antigens; we aimed to evaluate the specificity of this test and to
assess the predictive value ofIgM positivity for a recent infection.
Methods: 145 specimens from about 1,450 samples ofthe diagnostic routine
of3 centers (10%) that were positive (P) or grey-zone reactive (GZR) by
AxSYM CMV IgM wcre ••""yed by lIn experimenal immunoblot (ill) th.r
employs 4 viral proteins (ppI50. p82, pp65 and p28) and 4 rAg coveting the
immunodominant epitopes ofpp150, pl30. pp52 and pp38. By IB criteria, a
sample is positive (P) when it reacts with at least 1 viral protein + 1 rAg or
with 3 rAg; a reactivity to 1 or 2 rAgs is an indeterminate (I) result; weak
rcactives (+ /-) or lack of bands were scored as negative (N). Additionally.
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132/145 sera were tested for IgG avidity by a commercial EIA; an avidity
index (AI) < 35% indicates an acute primary infection, 35-45% a recent
primary infection and > 45% an old (> 6 months) infection.
Results: by IB 87 samples (60%) were P, 42 (29%) I and 16 (11 %) N,
resulting in a specificity ofAxSYM CMV IgM of98.8%. The Index value of
AxSYM results was predictive of a positive ill result, since only 35% of
GZR/weak reactives were P by IB vs. 69% ofmedium/strong reactives (p <
0.01). An AI < 35% wasrecorded in 7 samples (5.3%), 35-45% in 8 (6.1 %)
and > 45% in 117 (88.6%), the number ofIB IgM positives being 7,5 and
71, respectively.
Conclusion: a specific IgM anti-CMV reactivity is often seen in routine
testing and it is due to an ongoing or recent primary infection (11 %) or to a
reactivation of latent infection (89%).
ITuP29SI Comparison of FLU OIA test versus direct
immunofluorescence staining for rapid diagnosis of influenza
virus type A and 8 infection
B. Zweygberg Wirgart l , A. lsal , C. Larsson2, B. Herrmann2
,Dept ofClinical Microbiology, Section of Virology, Karolinska Hospital,
Stockholm; 2DeptofClinicai Microbiology, Seaion of Virology. University
Hospital, Uppsala, Sweden
Objectives: To compare the performance of a new optical immuno assay,
the Biostar FLU OIA test, with direct immunofluorescence (IF) staining for
rapid detection of influenza virus A and B antigens in nasopharyngeal
specimens.
Methods: Nasopharyngeal swabs and aspirates were obtained from 152
patients with a suspect influenza virus infection. The swabs were subjected
for FLU OIA testing according to the manufacturers instructions while the
aspirates were used for direct IF detection using Imagen influenza type A and
B monoclonals (Dako AS, Denmark). The FLU OIA test detects influenza
virus nucleoprotein antigens but cannot distinguish between influenza A and
B. Positive OIA results were scored + to + + + +.
Results: Influenza virus A was detected in 77/152 aspirates examined by IF
while 78/152 swabs scored positive by OIA (+ to + + + +). Discrepant
results occurred in 33 cases (IF + /OIA- in 16 cases, IF-/OIA + in 17 cases).
The sensitivity and specificity of our IF test compared to virus isolation is
more than 85% and 95%, respectively. Using IF as the reference method, the
OIA test had a sensitivity of79% (61/77) and a specificity of 77% (58/75).
The corresponding figures were 66% and 88%, respectively ifonly the + +
to + + + + positive OIA tests were considered as positive.
Conclusions: FLU OIA is useful for rapid detection of influenza vires and
can provide the clinician with a prclim.inary result. The sensitivity and
specificity is however lower than for IF. The test need to be further
evaluated.
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!TuP299I The value of gram stain and Acridine orange
leucocyte cytospin tests in the detection of asymptomatic
bacterial colonization of central venous catheters
J,J, Bong!, P. Kite2, B.J, Ammori!, M. H. Wilcox2, M.J. McMahonI
1Academic Surgical Unit; 2Departmmt ofMicrobiology, The Getreral
Injirmary, Leeds, United Kingdom LSI 3EX
Objectives: To investigate the value of Acridine orange leucocyte cytospin
(AOLC) test in screening for asymptomatic colonized catheters.
Methods: A prospective trial was conducted on adult patients requiring
central venous access for TPN. One week after catheter insertion, AOLC
test was performed on all catheters. Catheters that were removed within 72
hours of screening were selected for the determination of test characteristic
of AOLC. Upon removal, all catheters were assessed by the roll-plate and
the endoluminal brush methods.
Results: AOLC tests on the 7th day after catheter insertion were performed
on 131 catheters, ofwhich 40 catheters were removed within 72 hours after
screening. AOLC tests were positive in two catheters, one of which led to
catheter-related bloodstream infection (CBI). Ofthe remaining 38 catheters
that had negative AOLC tests, 6 catheters were colonized upon removal.
The sensitivity, specificity, negative predictive value and positive predictive
value of AOLC on day seven for the detection ofendoluminaI colonization
ofCVC were 14%, 97%, 82% and 50% respectively. OveraII, there were 11
(8%) cases ofCBJ, which occurred from 3 to 39 days poot screening (median
16 days). Upon removal, 15 of 131 catheters (11%) were found to be
colonized endoluminally (median lifespan = 11 days, range 7-88 days).
Condusions: Despite the previously documented value of the AOLC tests
to confirm the existence of suspected CBI, the present study suggests that
they are not sufficiently sensitive to detect low-grade colonization that may
lead to CBI later.
ITuP300I Evluation of Bactec bloodcultures at a small
university unit
E. Keuleyan, R. Gergova, I. Haralambieva, L. Boyanova, G. Gergova, T.
Ilieva, N. Gigova, I. Mitov, Y. Dotcheva
Dept. Microbiology, Medical University, Sojia, Bulgaria
Objectives: To assess Bactec bloodculture surveillance for 3-year period in a
small university unit.
Methods: Bloodculrures from clinics for Trauma and Orthopedics, Internal
Diseases and Therapy, Gastro-et.terology, Rheumatology and Pneumology
ICU performed in Bactec, Becton Dickinson system, 1997-1999, were
evaluated. Identification of microorganisms was by routine procedure.
Susceptibility testing was by disk diffusion method by NCCLS and/or by
Sceptor system, BBL..
Results: A total 1114 bloodcultures were performed with average percent of
positive 12.8%, respectively/year 14.3%,11.3% and 9.1%. The number of
Gram-positive microorganisms was 3.6 fold than Gram-negative isolates.
The leading cause of bacteremia were coagulase-negative Staphylococcus
(CoNS) - 30 cases, followed by S. pneumoniae (Sp) (15), S. aureus (Sau)
(11), E. faecalis (Efae) (4). The first top Gram-negative species were: A.
baumannii (6), E. cloacae and S. marcescms (by 4), E. coli (3), E. aerogerres and P.
mirabilis (by 2). The other isolates were K. pneumoniae, Salmontllagt. C, C.
fteundii, P. aeruginosa, A. lwojii, F. indologmes. Four cases represented a
polymicrobial bacteremia. The average rate ofpositive anaerobic bacteremia
was 0.6%, the most interesting isolates representing C. paraputrijKum and C.
histolyticum. Fungi were isolated from 2 patients. Susceptibility testing results
have shown a high incidence of methicillin-resistant Staphylococcus, rapre-
senting 60% for CoNS and 45% for Sau. 33% ofSp were penicillin-resistant.
No vancomycin-resistant E fae was isolated. Gram-negative isolates were
more susceptible than isolates from other sites of infection.
Condusions: Although the Bactec system is well appreciated by the clin-
icians due to the more rapid and reliable results, much more blood culture
samples are nceded for the precise diagnosis of sepsis and infective endo-
carditis and respectively a better funding for this purpose for the Clinical
Microbiology Laboratory.
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Objectives: To perform the external evaluation of quality performance in
clinical microbiology laboratories in Poland. Since 1993 the National
External Quality Assessment Scheme (NEQAS) has been organised
annually. The 1999 NEQAS edition took place in spring and autumn.
The programme is financed by the Polish Ministry of Health and Social
Welfare.
Methods: In spring each of 272 participating laboratories received 2
microscope slides with smears obtained from diagnostic materials
(sputum, pus) and the clinical description of patients from whom the
specimens were collected. Participants received also a questionnaire for
evaluation of their analysis of the clinical materials, the preliminary identi-
fication of etiological agents, and proposals for further processing of the
materials. In autumn each of 275 participating laboratories was asked to
collect 5 consecutive isolates ofStaphylococcus aureus, identified as etiological
agents of infections during the routine work and send them together with
identification and susceptibility data to the Centre of Quality Control for
retesting. The following parameters were evaluated: species identification,
selection of antimicrobials for susceptibility testing, determination of sus-
ceptibility, and interpretation of results.
Results: Each laboratory received the spring test evaluation report, the
individual comment and ranking of the laboratory. Two hundred and
eleven laboratories (77.6%) were classified as credible. Sputum specimen
evalu2tion by Gr:un sWn was the most difficult. Preliminary data of the
